It has been described that HDAC inhibition produces cell cycle arrest, the inhibition of tumor angiogenesis, differentiation of some transformed cell lines14 and/or apoptosis in tumor cells4,5,15, showing particular importance as a pharmacological target for cancer treatment. The gene discussed is HDAC9; the disease is neoplasm.